Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
08/2006
08/01/2006US7084161 Method for treating inflammatory diseases or conditions
08/01/2006US7084160 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents
08/01/2006US7084158 Substituted propargylamines
08/01/2006US7084149 Anticancer agents; antitumor agents
08/01/2006US7084137 Treating glues, sizes, paper and board, textiles, leather, wood, wooden materials, paints, synthetic articles, cooling lubricants with a thiazine microbiocides; chemical synthesis from isothiocyanate; used as fungicides, batericides, miticides, insecticides, nematocides
08/01/2006US7084136 Drug composition antagonistic to both PGD2/TXA2 receptors
08/01/2006CA2245823C Farnesyl transferase inhibitors
07/2006
07/27/2006WO2006078621A2 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
07/27/2006WO2006078037A1 Process for producing thiazolidinedione compound and production intermediate thereof
07/27/2006WO2006077206A1 New 3-phenylpropionic acid derivatives and their use as ppar- gamma rezeptor liganden
07/27/2006WO2006066173A3 Novel mch receptor antagonists
07/27/2006WO2006034315A3 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
07/27/2006US20060167267 Michael-type addition of a nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and the conversion of a ester moiety into an amino moiety; S)-2-methylcysteine; desferrithiocin
07/27/2006US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
07/27/2006US20060167014 Piperazine compounds and medicinal use thereof
07/27/2006US20060166990 Novel aminobenzophenone compounds
07/27/2006US20060166987 Therapy for obesity; using secondary amino compound
07/27/2006US20060166866 Cell adhesion inhibitors
07/27/2006CA2619153A1 Regulation of protein synthesis by inhibition of eif4e-eif4g interaction
07/26/2006EP1683804A2 Platinum complex and luminescent element
07/26/2006EP1682538A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications
07/26/2006EP1682515A1 Method for the production of fluoromethyl-substituted heterocycles
07/26/2006EP1682129A1 N-thiazol-2-yl-benzamide derivatives
07/26/2006EP1682127A1 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters
07/26/2006EP1681924A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
07/26/2006EP1414447B1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria
07/26/2006CN1809561A Phenylacetamides and their use as glucokinase modulators
07/26/2006CN1809544A Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
07/26/2006CN1809543A Nematicidal thiazoline-containing fluorobutenes
07/26/2006CN1809541A Aniline derivatives
07/26/2006CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
07/25/2006US7081537 Process for the electrophilic substitution of thiazolidines or oxazolidines
07/20/2006WO2006076706A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
07/20/2006WO2006076702A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ĸB ACTIVITY AND USE THEREOF
07/20/2006WO2006076633A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
07/20/2006WO2006076509A1 Heterocyclic modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
07/20/2006WO2006074884A1 Thiazole-4-carboxamide derivatives as mglur5 antagonists
07/20/2006WO2006047269A3 Pharmaceutical compositions
07/20/2006US20060161007 Oxazole and thiazole combinatorial libraries
07/20/2006US20060160894 Benzamides as ppar modulators
07/20/2006US20060160875 Matrix metalloproteinase inhibitors
07/20/2006US20060160869 Ubiquitin ligase inhibitors
07/20/2006US20060160856 Diarylurea derivatives and their use as chloride channel blockers
07/20/2006US20060160832 Nitrogen-containing aromatic derivatives
07/20/2006US20060160797 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/20/2006US20060160796 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
07/20/2006US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy
07/20/2006DE4327748B4 Cyclopropyl- und Cyclobutyl-Derivate Cyclopropyl and cyclobutyl derivatives
07/20/2006CA2594871A1 Exo- and diastereo- selective syntheses of himbacine analogs
07/20/2006CA2594860A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
07/20/2006CA2593439A1 Thiazole-4-carboxamide derivatives as mglur5 antagonists
07/19/2006EP1681285A1 Diamine derivative, process for producing the same, and plant disease control agent containing the same as active ingredient
07/19/2006EP1680472A2 Compounds for dual photodiagnosis and therapy
07/19/2006EP1680431A1 Benzothiazole and thiazole'5,5-b!pyridine compositions and their use as ubiquitin ligase inhibitors
07/19/2006EP1680410A1 Thiazole-2-carboxamide derivatives for use as hppar agonists in the treatment of i.a. dyslipidemia
07/19/2006EP1680408A2 Ccr3 receptor antagonists
07/19/2006EP1680407A1 Isopentyl carboxanilides for combating undesired micro-organisms
07/19/2006EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
07/19/2006EP1194146B1 Arylthiazolidinedione and aryloxazolidinedione derivatives
07/19/2006CN1805945A Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
07/19/2006CN1805923A Benzamide derivative or salt thereof
07/19/2006CN1805745A 2-aminobenzothiazoles as CB1 receptor inverse agonists
07/19/2006CN1803797A Inhibitors of dipeptidyl peptidase IV
07/19/2006CN1803783A Halogen atom-containing bidentate ligand, its iridium complex and electrogenerated phosphorescence device
07/19/2006CN1803782A Method for synthesizing 4-methyl-5-methyol thiazole
07/19/2006CN1803776A Substituted benzoyl carbamidine derivative, its preparation method and medical uses
07/19/2006CN1264826C Process for preparing alcohol by heterocyclic carboxylic ester reduction
07/18/2006US7078565 Benzamide derivatives as antagonists of orexin receptors
07/18/2006US7078527 reacting a 1-halo, mesylate, or tosylate-4,4-difluorobutene with a thiocyanate, giving a butenylthiocyanate; converting to a dithiocarbamate by reacting with hydrogen sulfide; condensation and cyclization with (chloro)acetaldehyde; circumvents 2-mercapto-1,3-thiazole intermediate; by-product inhibition
07/18/2006US7078422 Activator for peroxisome proliferator-activated receptor
07/18/2006US7078421 Substituted phenylacetic acids
07/18/2006US7078397 Comprises thiadiazolidinedione-based insulin sensitizers (troglitazone); peroxisome proliferator-activated receptors
07/18/2006CA2407416C Alkynyl phenyl heteroaromatic glucokinase activators
07/13/2006WO2006074262A1 Ubiquitin ligase inhibitors
07/13/2006WO2006073202A1 METHOD OF TUMOR SUPPRESSION AND EVALUATION OF ANTICANCER AGENT BASED ON GSK3β INHIBITORY EFFECT
07/13/2006WO2006072436A1 [4-(heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
07/13/2006WO2006002088A3 Amino-quinazoline derivatives as antitumor agents
07/13/2006WO2005112945A3 Synthesis of tetracyclines and analogues thereof
07/13/2006US20060155122 Thiazol-(bi)cycloalkyl-carboxanilides
07/13/2006US20060154974 N-thiazol-2-yl-benzamide derivatives
07/13/2006US20060154922 Muscarinic agonists
07/13/2006US20060154899 Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
07/13/2006US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting
07/13/2006CA2593463A1 [4-(heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
07/13/2006CA2592953A1 Rigidified compounds for modulating heparanase activity
07/13/2006CA2589830A1 Ubiquitin ligase inhibitors
07/12/2006EP1679310A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring
07/12/2006EP1678153A1 Thiozolidinones, production and use thereof as medicaments
07/12/2006EP1678142A1 Hexyl carboxanilides and their use for controlling undesirable micro-organisms
07/12/2006EP1678141A1 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
07/12/2006EP1678121A2 Tao kinase modulators and methods of use
07/12/2006EP1335923B1 Condensed pyridoindole derivatives
07/12/2006CN1800176A Heterocyclic sulfonamide inhibitors of beta amyloid production
07/12/2006CN1263750C Heterocyclic sulfonamide inhibitors from beta amyloid
07/12/2006CN1263748C A process for the preparation of bis-benzazolyl compounds
07/12/2006CN1263745C Aryl fused azapolycyclic compounds
07/12/2006CN1263739C Carboxypeptidase U suppressed compound and its preparation method, pharmaceutical composition containing the compound and its uses
07/11/2006US7074934 Serine protease inhibitors
07/11/2006CA2168447C Compounds and methods for inhibition of hiv and related viruses
07/06/2006WO2006071103A1 Organoselenium containing compounds and their use